Market Cap | 43.40M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -33.45M | Forward P/E | -0.79 | EPS next Y | - | 50D Avg Chg | -4.00% |
Sales | 51.69M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -9.00% |
Dividend | N/A | Price/Book | 1.27 | EPS next 5Y | - | 52W High Chg | -92.00% |
Recommedations | 2.00 | Quick Ratio | 0.88 | Shares Outstanding | 8.88M | 52W Low Chg | 64.00% |
Insider Own | 0.43% | ROA | -27.35% | Shares Float | 2.73M | Beta | 4.61 |
Inst Own | 68.81% | ROE | -160.08% | Shares Shorted/Prior | 37.42K/2.06K | Price | 0.25 |
Gross Margin | 54.18% | Profit Margin | -64.71% | Avg. Volume | 4,339,848 | Target Price | - |
Oper. Margin | -50.95% | Earnings Date | Oct 2 | Volume | 216,639 | Change | -2.35% |
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
NEW ENTERPRISE ASSOCIATES 13 L... | 10% Owner 10% Owner | Feb 09 | Buy | 0.2046 | 24,437,927 | 5,000,000 | 34,437,052 | 02/10/23 |
NEW ENTERPRISE ASSOCIATES 13 L... | 10% Owner 10% Owner | Oct 26 | Buy | 12 | 1,300,000 | 15,600,000 | 9,999,125 | 10/28/21 |